Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
ANIXAnixa Biosciences Inc
| Figure | ANIXAnixa Biosciences IncFY2024 · Oct |
|---|---|
| Revenue | $210.00K |
| Revenue, yoy | ±0.0% |
| Net income | $10.93M |
| Net income, yoy | +13.0% |
| Net margin | — |
| Free cash flow | $6.19M |
| FCF margin | — |
| EPS, diluted | $0.34 |
Add another company.
Annual · FY2018–FY2024 · USD
From SEC EDGARSame fiscal periods, as filed